Provider
The company targets to receive a similar clearance from the US FDA by yearend.
Panelists at ViVE 2023 discussed the future of preventive medicine as retail chains and virtual care players push into the space and more patients avoid primary care altogether.
During a discussion at ViVE 2023, panelists emphasized the need to interrogate data and know how it could be biased.
It has been approved for use in both clinical and home settings.
It seeks to support and accelerate the development of personalised healthcare and drug discovery.
The company will use the funds to continue its growth in the U.S.
During a discussion at ViVE 2023, panelists discussed how technology could make it easier for patients to access healthcare.
HIMSS23
Russ Hinz of Advocate Health, Stephanie Chia of University of Chicago Medicine and Susan Tolin from Chartis preview their HIMSS23 presentation on the South Side Healthy Community Organization.
The company has let go of approximately 35% of its workforce.
The latest cohort includes 23 companies focused on technology for retaining, deploying and training healthcare workers.